Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01106898
Title Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Treating Women With Stage I or Stage II Breast Cancer Who Have Undergone Surgery
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska

breast cancer


Cyclophosphamide + Paclitaxel


Age Groups: adult
Covered Countries USA

No variant requirements are available.